The DREAM complex: master coordinator of cell cycle-dependent gene expression

Molecular portraits of human breast tumours

Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551

Integrated genomic analyses of ovarian carcinoma

Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092

The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP

Huang, J., Wu, S., Barrera, J. A., Matthews, K. A., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,917

The Hippo pathway and human cancer

Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3458 · Cited by 1,867

Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors

Whitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. I., Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0030 · Cited by 1,527

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP

Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418

The history and future of targeting cyclin-dependent kinases in cancer therapy

Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype

Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622

Cell cycle regulation: p53-p21-RB signaling

Engeland, K. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00988-z · Cited by 1,367

The multiple mechanisms that regulate p53 activity and cell fate

Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129

Census and evaluation of p53 target genes

Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome

Huttlin, E. L., Bruckner, R. J., Navarrete-Perea, J., Cannon, J. R., Baltier, K., Gebreab, F., Gygi, M. P., Thornock, A., Zarraga, G., Tam, S., et al. (2020) · doi:10.1101/2020.01.19.905109 · Cited by 960

Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

Engeland, K. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.172 · Cited by 679

Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence

Miller, I., Min, M., Yang, C., Tian, C., Gookin, S. E., Carter, D., & Spencer, S. L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.110 · Cited by 637

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy

Pal, A., & Kundu, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03116 · Cited by 615

Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression

Ruijtenberg, S., & van den Heuvel, S. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1120925 · Cited by 577

Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes

Wang, T.-W., Johmura, Y., Suzuki, N., Omori, S., Migita, T., Yamaguchi, K., Hatakeyama, S., Yamazaki, S., Shimizu, E., Imoto, S., et al. (2022) · Nature · doi:10.1038/s41586-022-05388-4 · Cited by 469

Targeting Cancer Cell Dormancy

Recasens, A., & Munoz, L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.004 · Cited by 356

Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks

Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330

The p53-p21-DREAM-CDE/CHR pathway regulates G 2 /M cell cycle genes

Fischer, M., Quaas, M., Steiner, L., & Engeland, K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv927 · Cited by 339

MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis

Musa, J., Aynaud, M.-M., Mirabeau, O., Delattre, O., & Grünewald, T. G. P. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.244 · Cited by 321

Ki-67 gene expression

Uxa, S., Castillo-Binder, P., Kohler, R., Stangner, K., Müller, G. A., & Engeland, K. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00823-x · Cited by 315

Rethinking HSF1 in Stress, Development, and Organismal Health

Li, J., Labbadia, J. P., & Morimoto, R. I. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.08.002 · Cited by 269

Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.

Fischer, M., & Müller, G. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1360836 · Cited by 255

Coordinating gene expression during the cell cycle

Fischer, M., Schade, A. E., Branigan, T. B., Müller, G. A., & DeCaprio, J. A. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.06.007 · Cited by 218

Targeting the RB-E2F pathway in breast cancer

Johnson, J., Thijssen, B., McDermott, U., Garnett, M. J., Wessels, L. F. A., & Bernards, R. (2016) · Oncogene · doi:10.1038/onc.2016.32 · Cited by 201

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors

Patel, A. J., Wan, Y., Al‐Ouran, R., Revelli, J., Cardenas, M., Oneissi, M., Liu, X., Jalali, A., Magnotti, J. F., Muzny, D. M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912858116 · Cited by 199

The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1and Cyclin D1 and induces cell cycle exit and neuronal differentiation

Soppa, U., Schumacher, J., Florencio Ortiz, V., Pasqualon, T., Tejedor, F., & Becker, W. (2014) · Cell Cycle · doi:10.4161/cc.29104 · Cited by 189

Drug-tolerant persister cells in cancer: the cutting edges and future directions

Pu, Y., Li, L., Peng, H., Liu, L., Heymann, D., Robert, C., Vallette, F. M., & Shen, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00815-5 · Cited by 189

Cohesin-Dependent and -Independent Mechanisms Mediate Chromosomal Contacts between Promoters and Enhancers

Thiecke, M. J., Wutz, G., Muhar, M., Tang, W., Bevan, S., Malysheva, V., Stocsits, R., Neumann, T., Zuber, J., Fraser, P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107929 · Cited by 177

Single-cell transcriptome maps of myeloid blood cell lineages in Drosophila

Cho, B., Yoon, S.-H., Lee, D., Koranteng, F., Tattikota, S. G., Cha, N., Shin, M., Do, H., Hu, Y., Oh, S. Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18135-y · Cited by 177

DYRK1A and cognition: A lifelong relationship

Arbonés, M. L., Thomazeau, A., Nakano-Kobayashi, A., Hagiwara, M., & Delabar, J. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.010 · Cited by 174

Combined inhibition of DYRK1A, SMAD, and trithorax pathways synergizes to induce robust replication in adult human beta cells

Wang, P., Karakose, E., Liu, H., Swartz, E., Ackeifi, C., Zlatanic, V., Wilson, J., González, B. J., Bender, A., Takane, K. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.005 · Cited by 162

RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy

Indovina, P., Pentimalli, F., Casini, N., Vocca, I., & Giordano, A. (2015) · Oncotarget · doi:10.18632/oncotarget.4286 · Cited by 165

KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism

Zhao, E., Ding, J., Xia, Y., Liu, M., Ye, B., Choi, J.-H., Yan, C., Dong, Z., Huang, S., Zha, Y., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.053 · Cited by 165

Transcriptional repression by MYB3R proteins regulates plant organ growth

Kobayashi, K., Suzuki, T., Iwata, E., Nakamichi, N., Suzuki, T., Chen, P., Ohtani, M., Ishida, T., Hosoya, H., Müller, S., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490899 · Cited by 160

Multicilin drives centriole biogenesis via E2f proteinsPreprint

Ma, L., Quigley, I. K., Omran, H., & Kintner, C. R. (2014) · Genes & Development · doi:10.1101/gad.243832.114 · Cited by 166

How the cell cycle impacts chromatin architecture and influences cell fate

Ma, Y., Kanakousaki, K., & Buttitta, L. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00019 · Cited by 166

DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications

Abbassi, R. H., Johns, T. G., Kassiou, M., & Munoz, L. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.004 · Cited by 156

Molecular mechanisms of the preventable causes of cancer in the United StatesPreprint

Golemis, E. A., Scheet, P. A., Beck, T. N., Scolnick, E. M., Hunter, D. J., Hawk, E. T., & Hopkins, N. H. (2018) · Genes & Development · doi:10.1101/gad.314849.118 · Cited by 164

The transcription factor p53: Not a repressor, solely an activator.

Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153

Transcriptional landscape of the human cell cycle

Liu, Y., Chen, S., Wang, S., Soares, F., Fischer, M., Meng, F., Du, Z., Lin, C. Y., Meyer, C. A., DeCaprio, J. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617636114 · Cited by 155

Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis

Zacksenhaus, E., Shrestha, M., Liu, J. C., Vorobieva, I., Chung, P. E. D., Ju, Y., Nir, U., & Jiang, Z. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.002 · Cited by 143

A regulatory module controlling stress-induced cell cycle arrest in Arabidopsis

Takahashi, N., Ogita, N., Takahashi, T., Taniguchi, S., Tanaka, M., Seki, M., & Umeda, M. (2019) · eLife · doi:10.7554/elife.43944 · Cited by 134

Molecular and functional heterogeneity of IL-10-producing CD4+ T cells

Brockmann, L., Soukou, S., Steglich, B., Czarnewski, P., Zhao, L., Wende, S., Bedke, T., Ergen, C., Manthey, C., Agalioti, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07581-4 · Cited by 136

CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities

Knudsen, E. S., Kumarasamy, V. M., Nambiar, R., Pearson, J. D., Vail, P. J., Rosenheck, H. R., Wang, J., Eng, K., Bremner, R., Schramek, D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110448 · Cited by 128

Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins

Haręża, D. A., Wilczyński, J. R., & Paradowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031818 · Cited by 138

Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes

Raab, J. R., Resnick, S. J., & Magnuson, T. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005748 · Cited by 133

Cancer metastasis: Molecular mechanisms and clinical perspectives

Khan, S. U., Fatima, K., Malik, F. A., Kalkavan, H., & Wani, A. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108522 · Cited by 127

The protein Compromised Hydrolysis of Triacylglycerols 7 (CHT7) acts as a repressor of cellular quiescence in Chlamydomonas

Tsai, C., Warakanont, J., Takeuchi, T., Sears, B. B., Moellering, E. R., & Benning, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414567111 · Cited by 118

Pan-cancer molecular analysis of the RB tumor suppressor pathway

Knudsen, E. S., Nambiar, R., Rosario, S. R., Smiraglia, D. J., Goodrich, D. W., & Witkiewicz, A. K. (2020) · Communications Biology · doi:10.1038/s42003-020-0873-9 · Cited by 123

Multiciliated Cells in Animals

Meunier, A., & Azimzadeh, J. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028233 · Cited by 117

Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma

Zhang, X. Z., Lv, Q., Huang, Y.-T., Zhang, L., & Zhou, H. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0573-6 · Cited by 114

Arabidopsis RETINOBLASTOMA RELATED directly regulates DNA damage responses through functions beyond cell cycle control

Horváth, B. M., Kourová, H., Nagy, S. K., Németh, E., Magyar, Z., Papdi, C., Ahmad, Z., Sanchez‐Perez, G. F., Perilli, S., Blilou, I., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201694561 · Cited by 117

Cell Cycle–Targeted Cancer Therapies

Sherr, C. J., & Bártek, J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-040716-075628 · Cited by 119

Structural mechanisms of DREAM complex assembly and regulationPreprint

Guiley, K. Z., Liban, T. J., Felthousen, J. G., Ramanan, P., Litovchick, L., & Rubin, S. M. (2015) · Genes & Development · doi:10.1101/gad.257568.114 · Cited by 119

DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation

Uxa, S., Bernhart, S. H., Mages, C. F., Fischer, M., Kohler, R., Hoffmann, S., Stadler, P. F., Engeland, K., & Müller, G. A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz635 · Cited by 121

MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer

Li, Q., Wang, M., Hu, Y., Zhao, E., Li, J., Ren, L., Wang, M., Xu, Y., Liang, Q., Zhang, D., et al. (2021) · Theranostics · doi:10.7150/thno.56604 · Cited by 112

DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis

Fernández, P., Zahonero, C., & Sánchez‐Gómez, P. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.970048 · Cited by 110

E2F coregulates an essential HSF developmental program that is distinct from the heat-shock responsePreprint

Li, J., Chauve, L., Phelps, G., Brielmann, R. M., & Morimoto, R. I. (2016) · Genes & Development · doi:10.1101/gad.283317.116 · Cited by 116

Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway

Fischer, M., Uxa, S., Stanko, C., Magin, T. M., & Engeland, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-02831-9 · Cited by 108

A map of directional genetic interactions in a metazoan cell

Fischer, B., Sandmann, T., Horn, T. L., Billmann, M., Chaudhary, V., Huber, W. K., & Boutros, M. (2015) · eLife · doi:10.7554/elife.05464 · Cited by 106

Roles of plant retinoblastoma protein: cell cycle and beyond

Desvoyes, B., & Gutiérrez, C. (2020) · The EMBO Journal · doi:10.15252/embj.2020105802 · Cited by 104

Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines

Campbell, J., Ryan, C. J., Brough, R., Bajrami, I., Pemberton, H. N., Chong, I. Y.-S., Costa-Cabral, S., Frankum, J. R., Gulati, A., Holme, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.023 · Cited by 104

C1 CAGE detects transcription start sites and enhancer activity at single-cell resolution

Kouno, T., Moody, J., Kwon, A. T.-J., Shibayama, Y., Kato, S., Huang, Y., Böttcher, M. E., Motakis, E., Mendez, M., Severin, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08126-5 · Cited by 101

Post-transcriptional RNA regulons affecting cell cycle and proliferation

Blackinton, J. G., & Keene, J. D. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.05.014 · Cited by 95

The human papillomavirus E7 oncoprotein as a regulator of transcription

Songock, W. K., Kim, S., & Bodily, J. M. (2016) · Virus Research · doi:10.1016/j.virusres.2016.10.017 · Cited by 97

Mechanisms of the CDK4/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review)

Liu, M., Liu, H., & Chen, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6221 · Cited by 91

Modelling Chlamydia and HPV co-infection in patient-derived ectocervix organoids reveals distinct cellular reprogramming

Koster, S., Gurumurthy, R. K., Kumar, N., Prakash, P. G., Dhanraj, J., Bayer, S., Berger, H., Kurian, S. M., Drabkina, M., Mollenkopf, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28569-1 · Cited by 93

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers

Tornesello, M. L., Annunziata, C., Tornesello, A. L., Buonaguro, L., & Buonaguro, F. M. (2018) · Cancers · doi:10.3390/cancers10070213 · Cited by 87

Histone supply: Multitiered regulation ensures chromatin dynamics throughout the cell cycle

Mendiratta, S., Gatto, A., & Almouzni, G. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201807179 · Cited by 94

KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes

Duan, L., Rai, G., Roggero, C. M., Zhang, Q.-J., Wei, Q., Ma, S. H., Zhou, Y., Santoyo, J., Martínez, E. D., Xiao, G., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.08.007 · Cited by 81

The Role of Merlin/NF2 Loss in Meningioma Biology

Lee, S., Karas, P. J., Hadley, C. C., Bayley, J. C., Khan, A. W., Jalali, A., Sweeney, A. D., Klisch, T. J., & Patel, A. J. (2019) · Cancers · doi:10.3390/cancers11111633 · Cited by 80

Cellular senescence and aging: the role of B‐ MYB

Mowla, S. N., Lam, E. W. ‐., & Jat, P. (2014) · Aging Cell · doi:10.1111/acel.12242 · Cited by 79

Spontaneously slow-cycling subpopulations of human cells originate from activation of stress-response pathways

Min, M., & Spencer, S. L. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000178 · Cited by 85

Biomarkers of Cellular Senescence and Aging: Current State‐of‐the‐Art, Challenges and Future Perspectives

Muthamil, S., Kim, H., Jang, H., Lyu, J., Shin, U. C., Go, Y., Park, S., Lee, H. G., & Park, J. H. (2024) · Advanced Biology · doi:10.1002/adbi.202400079 · Cited by 82

Next-Generation Sequencing Reveals Low-Dose Effects of Cationic Dendrimers in Primary Human Bronchial Epithelial Cells

Feliu, N., Kohonen, P. J., Ji, J., Zhang, Y., Karlsson, H. L., Palmberg, L., Nyström, A. M., & Fadeel, B. (2014) · ACS Nano · doi:10.1021/nn5061783 · Cited by 79

Expression dynamics, relationships, and transcriptional regulations of diverse transcripts in mouse spermatogenic cells

Lin, X., Han, M., Cheng, L., Chen, J., Zhang, Z., Shen, T., Wang, M., Wen, B., Ni, T., & Han, C. (2016) · RNA Biology · doi:10.1080/15476286.2016.1218588 · Cited by 80

The DREAM complex functions as conserved master regulator of somatic DNA-repair capacities

Bujarrabal-Dueso, A., Sendtner, G., Meyer, D. H., Chatzinikolaou, G., Stratigi, K., Garinis, G. A., & Schumacher, B. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-00942-8 · Cited by 79

Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer

Wiecek, A. J., Cutty, S. J., Kornai, D., Parreno-Centeno, M., Gourmet, L. E., Tagliazucchi, G. M., Jacobson, D. H., Zhang, P., Xiong, L., Bond, G. L., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02963-4 · Cited by 83

E2F4 regulates transcriptional activation in mouse embryonic stem cells independently of the RB family

Hsu, J. C., Arand, J., Chaikovsky, A. C., Mooney, N. A., Demeter, J., Brison, C. M., Oliverio, R., Vogel, H. S., Rubin, S. M., Jackson, P. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10901-x · Cited by 82

p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells

Periyasamy, M., Singh, A. K., Gemma, C., Kranjec, C., Farzan, R. A., Leach, D. A., Navaratnam, N., Pálinkás, H. L., Vértessy, B. G., Fenton, T. R., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx721 · Cited by 79

Ki-67 Contributes to Normal Cell Cycle Progression and Inactive X Heterochromatin in p21 Checkpoint-Proficient Human Cells

Sun, X., Bizhanova, A., Matheson, T. D., Yu, J., Zhu, L. J., & Kaufman, P. D. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00569-16 · Cited by 76

YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells

Wei, T., Weiler, S. M. E., Tóth, M., Sticht, C., Lutz, T., Thomann, S., Torre, C. D. L., Straub, B. K., Merker, S., Ruppert, T., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0801-y · Cited by 76

RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation

Schade, A. E., Fischer, M., & DeCaprio, J. A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz961 · Cited by 74

DREAM complex suppresses DNA methylation maintenance genes and precludes DNA hypermethylation

Ning, Y., Liu, N., Lan, K.-K., Su, Y., Li, L., Chen, S., & He, X. (2020) · Nature Plants · doi:10.1038/s41477-020-0710-7 · Cited by 74

Nanos genes and their role in development and beyond

Keuckelaere, E. D., Hulpiau, P., Saeys, Y., Berx, G., & Roy, F. M. V. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2766-3 · Cited by 74

Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies

Min, H.-Y., & Lee, H. (2023) · Cancer Research and Treatment · doi:10.4143/crt.2023.468 · Cited by 78

Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis

Shi, C., Huang, D., Lü, N., Chen, D., Zhang, M., Yan, Y., Deng, L., Lu, Q., Lu, H., & Luo, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8441 · Cited by 73

Complex Cartography: Regulation of E2F Transcription Factors by Cyclin F and Ubiquitin

Emanuele, M. J., Enrico, T. P., Mouery, R. D., Wasserman, D., Nachum, S., & Tzur, A. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.05.002 · Cited by 72

Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control

Klein, D. K., Hoffmann, S., Ahlskog, J. K., O’Hanlon, K. A., Quaas, M., Larsen, B. D., Rolland, B., Rösner, H. I., Walter, D., Kousholt, A. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms6800 · Cited by 72

A wake‐up call to quiescent cancer cells – potential use of DYRK 1B inhibitors in cancer therapy

Becker, W. B. (2017) · FEBS Journal · doi:10.1111/febs.14347 · Cited by 76

Dedifferentiation and neuronal repression define familial Alzheimer’s disease

Caldwell, A. B., Liu, Q., Schroth, G. P., Galasko, D. R., Yuan, S. H., Wagner, S. L., & Subramaniam, S. (2020) · Science Advances · doi:10.1126/sciadv.aba5933 · Cited by 69

Autophagy and Cancer Dormancy

Akkoç, Y., Peker, N., Akçay, A., & Gözüaçık, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.627023 · Cited by 71

Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse

Lindell, E., Zhong, L., & Zhang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043762 · Cited by 75

CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition

Abdolazimi, Y., Zhao, Z., Lee, S., Xu, H., Allegretti, P. A., Horton, T. M., Yeh, B. T., Moeller, H. P., Nichols, R. J., McCutcheon, D., et al. (2018) · Endocrinology · doi:10.1210/en.2018-00083 · Cited by 68

A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy

MacDonald, J. I., Ramos-Valdes, Y., Perampalam, P., Litovchick, L., DiMattia, G. E., & Dick, F. A. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0323-t · Cited by 67

At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity

Rizzotto, D., Englmaier, L., & Villunger, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910883 · Cited by 69

The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes

Pattschull, G., Walz, S., Gründl, M., Schwab, M., Rühl, E., Baluapuri, A., Vranesic, A. C., Kneitz, S., Wolf, E., Ade, C. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.071 · Cited by 68

The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb

Iness, A. N., Felthousen, J. G., Ananthapadmanabhan, V., Sesay, F. F., Saini, S., Guiley, K. Z., Rubin, S. M., Dozmorov, M. G., & Litovchick, L. (2018) · Oncogene · doi:10.1038/s41388-018-0490-y · Cited by 65

Structural basis for LIN54 recognition of CHR elements in cell cycle-regulated promoters

Marceau, A. H., Felthousen, J. G., Goetsch, P. D., Iness, A. N., Lee, H., Tripathi, S. M., Strome, S., Litovchick, L., & Rubin, S. M. (2016) · Nature Communications · doi:10.1038/ncomms12301 · Cited by 68

Identification of Drivers of Aneuploidy in Breast Tumors

Pfister, K. E., Pipka, J. L., Chiang, C., Liu, Y., Clark, R. A., Keller, R. E., Skoglund, P., Guertin, M. J., Hall, I. M., & Stukenberg, P. T. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.102 · Cited by 65

FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways

Kelleher, F. C., & O’Sullivan, H. (2016) · Oncotarget · doi:10.18632/oncotarget.8669 · Cited by 64

Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation

Cuitiño, M. C., Pécot, T., Sun, D., Kladney, R. D., Okano‐Uchida, T., Shinde, N., Saeed, R., Perez-Castro, A., Webb, A., Liu, T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.004 · Cited by 66

Nitrogen-dependent coordination of cell cycle, quiescence and TAG accumulation in Chlamydomonas

Takeuchi, T., & Benning, C. (2019) · Biotechnology for Biofuels · doi:10.1186/s13068-019-1635-0 · Cited by 66

Mechanistic Insights Into DREAM and RB Control of the Cell Cycle

Schade, A. E. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1

DREAM On: Cell Cycle Control in Development and Disease

Walston, H. C., Iness, A. N., & Litovchick, L. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071819-103836 · Cited by 51

Cyclin D–CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB

Schade, A. E., Oser, M. G., Nicholson, H. E., & DeCaprio, J. A. (2019) · Oncogene · doi:10.1038/s41388-019-0767-9 · Cited by 73

DREAMs in Cancer Cell Quiescence and Beyond

Kim, M. (2023) · Pan American Health Care Exchanges · doi:10.1109/gmepe/pahce58559.2023.10226473

A Dual Role for the dREAM/MMB Complex in the Regulation of Differentiation-Specific E2F/RB Target Genes

Lee, H., Ragusano, L., Martinez, A., Gill, J., & Dimova, D. K. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06314-11 · Cited by 18